Dysferlin regulates cell membrane repair by facilitating injury-triggered acid sphingomyelinase secretion

Cell Death and Disease

Volumn 5, Issue 6, 2014, Pages

  Defour, A ^a   Van Der Meulen, J H ^a   Bhat, R ^a   Bigot, A ^b   Bashir, R ^c   Nagaraju, K ^a,d   Jaiswal, J K ^a,d  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b INSERM   (France)

^c DURHAM UNIVERSITY   (United Kingdom)

^d GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYSFERLIN; SPHINGOMYELIN PHOSPHODIESTERASE; DYSF PROTEIN, HUMAN; DYSF PROTEIN, MOUSE; MEMBRANE PROTEIN; MUSCLE PROTEIN;

ANIMAL CELL; ARTICLE; CELL DAMAGE; CELL DIFFERENTIATION; CONTROLLED STUDY; DYSFERLINOPATHY; ENZYME RELEASE; EXOCYTOSIS; HUMAN; HUMAN CELL; INTRACELLULAR MEMBRANE; LYSOSOME; MOUSE; MUSCLE CELL; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; ANIMAL; CELL LINE; DISTAL MYOPATHIES; GENETICS; METABOLISM; MUSCULAR ATROPHY; PATHOLOGY; SARCOLEMMA; SECRETION (PROCESS);

ANIMALS; CELL LINE; DISTAL MYOPATHIES; EXOCYTOSIS; HUMANS; MEMBRANE PROTEINS; MICE; MUSCLE PROTEINS; MUSCULAR ATROPHY; MYOBLASTS, SKELETAL; SARCOLEMMA; SPHINGOMYELIN PHOSPHODIESTERASE;

EID: 84903783256     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2014.272     Document Type: Article

References (58)

1. Bashir R, Britton S, Strachan T, Keers S, Vafiadaki E, Lako M et al. A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B. Nat Genet 1998; 20: 37-42.
2. Liu J, Aoki M, Illa I, Wu C, Fardeau M, Angelini C et al. Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy. Nat Genet 1998; 20: 31-36.
3. Cenacchi G, Fanin M, De Giorgi LB, Angelini C. Ultrastructural changes in dysferlinopathy support defective membrane repair mechanism. J Clin Pathol 2005; 58: 190-195.
4. Demonbreun AR, Fahrenbach JP, Deveaux K, Earley JU, Pytel P, McNally EM. Impaired muscle growth and response to insulin-like growth factor 1 in dysferlin-mediated muscular dystrophy. Hum Mol Genet 2011; 20: 779-789.
5. Bansal D, Miyake K, Vogel SS, Groh S, Chen CC, Williamson R et al. Defective membrane repair in dysferlin-deficient muscular dystrophy. Nature 2003; 423: 168-172.
6. Ho M, Post CM, Donahue LR, Lidov HG, Bronson RT, Goolsby H et al. Disruption of muscle membrane and phenotype divergence in two novel mouse models of dysferlin deficiency. Hum Mol Genet 2004; 13: 1999-2010.
7. Gallardo E, Rojas-Garcia R, de LN, Pou A, Brown Jr RH, Illa I. Inflammation in dysferlin myopathy: immunohistochemical characterization of 13 patients. Neurology 2001; 57: 2136-2138.
8. Bonnemann CG, McNally EM, Kunkel LM. Beyond dystrophin: current progress in the muscular dystrophies. Curr Opin Pediatr 1996; 8: 569-582.
9. Lek A, Evesson FJ, Sutton RB, North KN, Cooper ST. Ferlins: regulators of vesicle fusion for auditory neurotransmission, receptor trafficking and membrane repair. Traffic 2012; 13: 185-194.
10. Posey Jr AD, Demonbreun A, McNally EM. Ferlin proteins in myoblast fusion and muscle growth. Curr Top Dev Biol 2011; 96: 203-230.
11. Lennon NJ, Kho A, Bacskai BJ, Perlmutter SL, Hyman BT, Brown Jr RH. Dysferlin interacts with annexins A1 and A2 and mediates sarcolemmal wound-healing. J Biol Chem 2003; 278: 50466-50473.
12. Kesari A, Fukuda M, Knoblach S, Bashir R, Nader GA, Rao D et al. Dysferlin deficiency shows compensatory induction of Rab27A/Slp2a that may contribute to inflammatory onset. Am J Pathol 2008; 173: 1476-1487.
13. Nagaraju K, Rawat R, Veszelovszky E, Thapliyal R, Kesari A, Sparks S et al. Dysferlin deficiency enhances monocyte phagocytosis: a model for the inflammatory onset of limbgirdle muscular dystrophy 2B. Am J Pathol 2008; 172: 774-785.
14. de Luna N, Gallardo E, Soriano M, Dominguez-Perles R, de la Torre C, Rojas-Garcia R et al. Absence of dysferlin alters myogenin expression and delays human muscle differentiation 'in vitro'. J Biol Chem 2006; 281: 17092-17098.
15. Humphrey GW, Mekhedov E, Blank PS. de MA, Pekkurnaz G, Nagaraju K et al. GREG cells, a dysferlin-deficient myogenic mouse cell line. Exp Cell Res 2012; 318: 127-135.
16. Philippi S, Bigot A, Marg A, Mouly V, Spuler S, Zacharias U. Dysferlin-deficient immortalized human myoblasts and myotubes as a useful tool to study dysferlinopathy. PLoS Curr 2012; 4: RRN1298.
17. Millay DP, Maillet M, Roche JA, Sargent MA, McNally EM, Bloch RJ et al. Genetic manipulation of dysferlin expression in skeletal muscle: novel insights into muscular dystrophy. Am J Pathol 2009; 175: 1817-1823.
18. Lostal W, Bartoli M, Bourg N, Roudaut C, Bentaib A, Miyake K et al. Efficient recovery of dysferlin deficiency by dual adeno-associated vector-mediated gene transfer. Hum Mol Genet 2010; 19: 1897-1907.
19. Han R. Muscle membrane repair and inflammatory attack in dysferlinopathy. Skelet Muscle 2011; 1: 11.
20. Borgonovo B, Cocucci E, Racchetti G, Podini P, Bachi A, Meldolesi J. Regulated exocytosis: a novel, widely expressed system. Nat Cell Biol 2002; 4: 955-962.
21. Corrotte M, Almeida PE, Tam C, Castro-Gomes T, Fernandes MC, Millis BA et al. Caveolae internalization repairs wounded cells and muscle fibers. Elife 2013; 2: e00926.
22. Sharma N, Medikayala S, Defour A, Rayavarapu S, Brown KJ, Hathout Y et al. Use of quantitative membrane proteomics identifies a novel role of mitochondria in healing injured muscles. J Biol Chem 2012; 287: 30455-30467.
23. Jaiswal JK, Marlow G, Summerill G, Mahjneh I, Mueller S, Hill M et al. Patients with a nondysferlin miyoshi myopathy have a novel membrane repair defect. Traffic 2007; 8: 77-88.
24. Han WQ, Xia M, Xu M, Boini KM, Ritter JK, Li NJ et al. Lysosome fusion to the cell membrane is mediated by the dysferlin C2A domain in coronary arterial endothelial cells. J Cell Sci 2012; 125: 1225-1234.
25. McNeil PL, Kirchhausen T. An emergency response team for membrane repair. Nat Rev Mol Cell Biol 2005; 6: 499-505.
26. McNeil PL, Terasaki M. Coping with the inevitable: how cells repair a torn surface membrane. Nat Cell Biol 2001; 3: E124-E129.
27. McNeil PL. Repairing a torn cell surface: make way, lysosomes to the rescue. J Cell Sci 2002; 115: 873-879.
28. McDade JR, Michele DE. Membrane damage-induced vesicle-vesicle fusion of dysferlincontaining vesicles in muscle cells requires microtubules and kinesin. Hum Mol Genet 2013; 23: 1677-1686.
29. Tam C, Idone V, Devlin C, Fernandes MC, Flannery A, He X et al. Exocytosis of acid sphingomyelinase by wounded cells promotes endocytosis and plasma membrane repair. J Cell Biol 2010; 189: 1027-1038.
30. Draeger A, Babiychuk EB. Ceramide in plasma membrane repair. Handb Exp Pharmacol 2013 341-353.
31. Belanto JJ, Diaz-Perez SV, Magyar CE, Maxwell MM, Yilmaz Y, Topp K et al. Dexamethasone induces dysferlin in myoblasts and enhances their myogenic differentiation. Neuromuscul Disord 2010; 20: 111-121.
32. Cohen TV, Cohen JE, Partridge TA. Myogenesis in dysferlin-deficient myoblasts is inhibited by an intrinsic inflammatory response. Neuromuscul Disord 2012; 22: 648-658.
33. Defour A, Sen Chandra S, Jaiswal JK. Imaging cell membrane injury and sub-cellular processes involved in repair. J Vis Exp 2014; e-pub ahead of print 24 March 2014; doi:10.3791/51106.
34. Reddy A, Caler EV, Andrews NW. Plasma membrane repair is mediated by Ca(2+)-regulated exocytosis of lysosomes. Cell 2001; 106: 157-169.
35. Jaiswal JK, Andrews NW, Simon SM. Membrane proximal lysosomes are the major vesicles responsible for calcium-dependent exocytosis in nonsecretory cells. J Cell Biol 2002; 159: 625-635.
36. Jaiswal JK, Chakrabarti S, Andrews NW, Simon SM. Synaptotagmin VII restricts fusion pore expansion during lysosomal exocytosis. PLoS Biol 2004; 2: E233.
37. Glover L, Brown RH Jr. Dysferlin in membrane trafficking and patch repair. Traffic 2007; 8: 785-794.
38. Chapman ER. How does synaptotagmin trigger neurotransmitter release? Annu Rev Biochem 2008; 77: 615-641.
39. Kerr JP, Ziman AP, Mueller AL, Muriel JM, Kleinhans-Welte E, Gumerson JD et al. Dysferlin stabilizes stress-induced Ca2+ signaling in the transverse tubule membrane. Proc Natl Acad Sci USA 2013; 110: 20831-20836.
40. Krahn M, Wein N, Bartoli M, Lostal W, Courrier S, Bourg-Alibert N et al. A naturally occurring human minidysferlin protein repairs sarcolemmal lesions in a mouse model of dysferlinopathy. Sci Transl Med 2010; 2: 50ra69.
41. Babiychuk EB, Monastyrskaya K, Potez S, Draeger A. Blebbing confers resistance against cell lysis. Cell Death Differ 2011; 18: 80-89.
42. Ferreira LF, Moylan JS, Stasko S, Smith JD, Campbell KS, Reid MB. Sphingomyelinase depresses force and calcium sensitivity of the contractile apparatus in mouse diaphragm muscle fibers. J Appl Physiol (1985) 2012; 112: 1538-1545.
43. Garnacho C, Dhami R, Simone E, Dziubla T, Leferovich J, Schuchman EH et al. Delivery of acid sphingomyelinase in normal and niemann-pick disease mice using intercellular adhesion molecule-1-targeted polymer nanocarriers. J Pharmacol Exp Ther 2008; 325: 400-408.
44. Han R, Kanagawa M, Yoshida-Moriguchi T, Rader EP, Ng RA, Michele DE et al. Basal lamina strengthens cell membrane integrity via the laminin G domain-binding motif of alpha-dystroglycan. Proc Natl Acad Sci USA 2009; 106: 12573-12579.
45. Selcen D, Stilling G, Engel AG. The earliest pathologic alterations in dysferlinopathy. Neurology 2001; 56: 1472-1481.
46. Klinge L, Laval S, Keers S, Haldane F, Straub V, Barresi R et al. From T-tubule to sarcolemma: damage-induced dysferlin translocation in early myogenesis. FASEB J 2007; 21: 1768-1776.
47. Sudhof TC. Synaptotagmins: why so many? J Biol Chem 2002; 277: 7629-7632.
48. Cai C, Masumiya H, Weisleder N, Matsuda N, Nishi M, Hwang M et al. MG53 nucleates assembly of cell membrane repair machinery. Nat Cell Biol 2009; 11: 56-64.
49. Zhao P, Xu L, Ait-Mou Y, de Tombe PP, Han R. Equal force recovery in dysferlin-deficient and wild-type muscles following saponin exposure. J Biomed Biotechnol 2011; 2011: 235216.
50. van Blitterswijk WJ, van der Luit AH, Veldman RJ, Verheij M, Borst J. Ceramide: second messenger or modulator of membrane structure and dynamics? Biochem J 2003; 369: 199-211.
51. Grassme H, Jendrossek V, Bock J, Riehle A, Gulbins E. Ceramide-rich membrane rafts mediate CD40 clustering. J Immunol 2002; 168: 298-307.
52. McNeil PL, Steinhardt RA. Plasma membrane disruption: repair, prevention, adaptation. Annu Rev Cell Dev Biol 2003; 19: 697-731.
53. Jaiswal JK, Lauritzen SP, Scheffer L, Sakaguchi M, Bunkenborg J, Simon SM et al. S100A11 is required for efficient plasma membrane repair and survival of invasive cancer cells. Nat Commun 2014; 5: 3795.
54. Heier CR, Damsker JM, Yu Q, Dillingham BC, Huynh T, Van der Meulen JH et al. VBP15, a novel anti-inflammatory and membrane-stabilizer, improves muscular dystrophy without side effects. EMBO Mol Med 2013; 5: 1569-1585.
55. Grassme H, Becker KA, Zhang Y, Gulbins E. Ceramide in bacterial infections and cystic fibrosis. Biol Chem 2008; 389: 1371-1379.
56. Turinsky J, Nagel GW, Elmendorf JS, Damrau-Abney A, Smith TR. Sphingomyelinase stimulates 2-deoxyglucose uptake by skeletal muscle. Biochem J 1996; 313(Pt 1): 215-222.
57. Schuchman EH. The pathogenesis and treatment of acid sphingomyelinase- deficient Niemann-Pick disease. J Inherit Metab Dis 2007; 30: 654-663.
58. Brooks SV, Faulkner JA. The magnitude of the initial injury induced by stretches of maximally activated muscle fibres of mice and rats increases in old age. J Physiol 1996; 497(Pt 2): 573-580.